Minocycline treatment for confluent and reticulated papillomatosis.

S. N. Chang, S. C. Kim, S. H. Lee, W. S. Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We report six cases of confluent and reticulated papillomatosis in which the skin lesions cleared almost completely after treatment with minocycline. Patients with confluent and reticulated papillomatosis often do not respond well to a variety of therapeutic agents. The response of confluent and reticulated papillomatosis to minocycline was first described in 1965. Although the pharmacologic mechanisms of minocycline in confluent and reticulated papillomatosis are unknown, we suggest that it should be considered as a first-choice therapeutic agent because of its marked effectiveness.

Original languageEnglish
Pages (from-to)454-457
Number of pages4
JournalCutis; cutaneous medicine for the practitioner
Volume57
Issue number6
Publication statusPublished - 1996 Jun 1

Fingerprint

Minocycline
Papilloma
Therapeutics
Skin

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Immunology and Allergy

Cite this

@article{b47636bb1fcd45be93745ea067415af8,
title = "Minocycline treatment for confluent and reticulated papillomatosis.",
abstract = "We report six cases of confluent and reticulated papillomatosis in which the skin lesions cleared almost completely after treatment with minocycline. Patients with confluent and reticulated papillomatosis often do not respond well to a variety of therapeutic agents. The response of confluent and reticulated papillomatosis to minocycline was first described in 1965. Although the pharmacologic mechanisms of minocycline in confluent and reticulated papillomatosis are unknown, we suggest that it should be considered as a first-choice therapeutic agent because of its marked effectiveness.",
author = "Chang, {S. N.} and Kim, {S. C.} and Lee, {S. H.} and Lee, {W. S.}",
year = "1996",
month = "6",
day = "1",
language = "English",
volume = "57",
pages = "454--457",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "6",

}

Minocycline treatment for confluent and reticulated papillomatosis. / Chang, S. N.; Kim, S. C.; Lee, S. H.; Lee, W. S.

In: Cutis; cutaneous medicine for the practitioner, Vol. 57, No. 6, 01.06.1996, p. 454-457.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Minocycline treatment for confluent and reticulated papillomatosis.

AU - Chang, S. N.

AU - Kim, S. C.

AU - Lee, S. H.

AU - Lee, W. S.

PY - 1996/6/1

Y1 - 1996/6/1

N2 - We report six cases of confluent and reticulated papillomatosis in which the skin lesions cleared almost completely after treatment with minocycline. Patients with confluent and reticulated papillomatosis often do not respond well to a variety of therapeutic agents. The response of confluent and reticulated papillomatosis to minocycline was first described in 1965. Although the pharmacologic mechanisms of minocycline in confluent and reticulated papillomatosis are unknown, we suggest that it should be considered as a first-choice therapeutic agent because of its marked effectiveness.

AB - We report six cases of confluent and reticulated papillomatosis in which the skin lesions cleared almost completely after treatment with minocycline. Patients with confluent and reticulated papillomatosis often do not respond well to a variety of therapeutic agents. The response of confluent and reticulated papillomatosis to minocycline was first described in 1965. Although the pharmacologic mechanisms of minocycline in confluent and reticulated papillomatosis are unknown, we suggest that it should be considered as a first-choice therapeutic agent because of its marked effectiveness.

UR - http://www.scopus.com/inward/record.url?scp=0030162963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030162963&partnerID=8YFLogxK

M3 - Article

C2 - 8804855

AN - SCOPUS:0030162963

VL - 57

SP - 454

EP - 457

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 6

ER -